131 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more
6-K
EX-99.1
BLU
Bellus Health Inc
16 Jun 23
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
4:21pm
to vote at the Special Meeting, excluding for this purpose any person required to be excluded pursuant to Multilateral Instrument 61-101 – Protection … for the purpose of entering into the Arrangement agreement and completing the Arrangement. The Purchaser has not carried on any activities to date other than
6-K
EX-99.1
BLU
Bellus Health Inc
6 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:05pm
INVESTOR SERVICES INC., IN THE ENVELOPE PROVIDED FOR THAT PURPOSE. PLEASE REFER TO THE ACCOMPANYING AMENDED AND RESTATED MANAGEMENT INFORMATION CIRCULAR FOR ADDITIONAL PARTICULARS.
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
IT TO THE COMPANY, C/O COMPUTERSHARE INVESTOR SERVICES INC., IN THE ENVELOPE PROVIDED FOR THAT PURPOSE. PLEASE REFER TO THE ACCOMPANYING AMENDED … of the Company or any optionee, for any purpose whatsoever, including, without limitation for the purpose of:
amendments of a “housekeeping” nature, which
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
at the Meeting by Shareholders present or represented by proxy and entitled to vote at the Meeting, excluding for this purpose any person required … Solicitation Agent
Risk Factors
INFORMATION CONCERNING THE MEETING
Purpose of the Meeting
Meeting Information
Attending the Meeting
Voting Instructions
6-K
EX-99.3
51zt6wvenpnm5js0jrzg
19 May 23
Current report (foreign)
5:27pm
6-K
EX-99.1
62w799pmbfep 2w1q
16 May 23
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
5:04pm
6-K
EX-99.3
8k4b 94zad4
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.2
0im68pg7 lbewp9yn9
27 Apr 23
Material Change Report
6:04am
6-K
EX-99.1
e21i3c
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
EX-99.2
m2fl6fj u7oqj158x
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
nmy 25ul64n86
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
ewkd0gm fyi
29 Mar 23
Current report (foreign)
5:26pm
SUPPL
vs9v9rp6pryz93y6
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
ipm6n0xa602v88u ivv4
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
mx0c11idlwjgjkq2ea0
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
yx1 je8p4icscv
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
30iukkt5vysljnkl31e1
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
f6sn8
13 Jul 22
Supplemental materials (foreign)
5:01pm
S-8
xb49 ih2ezx119sp
19 Apr 22
Registration of securities for employees
4:14pm